These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Efficacy and safety of extended-duration inpatient-to-outpatient rabbit antithymocyte globulin induction in de novo kidney transplant recipients: 6-month outcomes. Trofe-Clark J; Reese PP; Patel HJ; Jakobowski D; Goral S; Doll SL; Abt PL; Bloom RD Transplantation; 2012 Sep; 94(5):506-12. PubMed ID: 22895613 [TBL] [Abstract][Full Text] [Related]
11. Renal transplantation in the setting of early steroid withdrawal: a comparison of rabbit antithymocyte globulin induction dosing in two eras. Rogers CC; Asipenko N; Horwedel T; Gautam S; Goldfarb-Rumyantzev AS; Pavlakis M; Johnson SR; Karp SJ; Evenson A; Khwaja K; Hanto DW; Mandelbrot DA Am J Nephrol; 2013; 38(5):397-404. PubMed ID: 24192457 [TBL] [Abstract][Full Text] [Related]
12. Characterization of rabbit antithymocyte globulins-induced CD25+ regulatory T cells from cells of patients with end-stage renal disease. Sewgobind VD; van der Laan LJ; Kho MM; Kraaijeveld R; Korevaar SS; van Dam T; Ijzermans JN; Weimar W; Baan CC Transplantation; 2010 Mar; 89(6):655-66. PubMed ID: 20164820 [TBL] [Abstract][Full Text] [Related]
14. Long-term evolution of lymphocytes subsets after induction therapy based on continuous versus discontinuous administration of anti-thymocyte globulins in renal-transplant patients. Esposito L; Kamar N; Tkaczuk J; Abbal M; Durand D; Rostaing L Transplant Proc; 2005 Mar; 37(2):785-7. PubMed ID: 15848531 [TBL] [Abstract][Full Text] [Related]
15. Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients. Klem P; Cooper JE; Weiss AS; Gralla J; Owen P; Chan L; Wiseman AC Transplantation; 2009 Oct; 88(7):891-6. PubMed ID: 19935460 [TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical outcome of low-dose and high-dose rabbit antithymocyte globulin induction therapy in renal transplantation: a single-center experience. Yang JW; Wang JN; Men TY; Zhang XM; Li XD; Shen B; Li GY; Chen DD Ann Transplant; 2014 Jun; 19():277-82. PubMed ID: 24906405 [TBL] [Abstract][Full Text] [Related]
17. Basiliximab combined with low-dose rabbit anti-human thymocyte globulin: a possible further step toward effective and minimally toxic T cell-targeted therapy in kidney transplantation. Ruggenenti P; Codreanu I; Cravedi P; Perna A; Gotti E; Remuzzi G Clin J Am Soc Nephrol; 2006 May; 1(3):546-54. PubMed ID: 17699258 [TBL] [Abstract][Full Text] [Related]
18. Kinetics of homeostatic proliferation and thymopoiesis after rATG induction therapy in kidney transplant patients. Bouvy AP; Kho MM; Klepper M; Litjens NH; Betjes MG; Weimar W; Baan CC Transplantation; 2013 Nov; 96(10):904-13. PubMed ID: 23985721 [TBL] [Abstract][Full Text] [Related]
19. Retreatment by antithymocyte globulin for second kidney transplantation: efficacy, tolerance and safety. Rodríguez-Reimundes E; Buron F; Chauvet C; Daoud S; Thaunat O; Brunet M; Badet L; Morelon E Transpl Immunol; 2013 Jan; 28(1):6-8. PubMed ID: 23220146 [TBL] [Abstract][Full Text] [Related]
20. Use of rabbit antithymocyte globulin in cardiac transplantation. Relationship of serum clearance rates to clinical outcome. Bieber CP; Griepp RB; Oyer PE; Wong J; Stinson EB Transplantation; 1976 Nov; 22(5):478-88. PubMed ID: 793103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]